quinolin-2-ylurea | 7671-86-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: quinolin-2-ylurea
• 英文别名: 2-quinolylurea；quinolin-2-yl-urea；(2-Chinolyl)-harnstoff；Quinolinylurea
• CAS: 7671-86-5
• 化学式: C₁₀H₉N₃O
• 分子量: 187.201
• InChiKey: IVBGRHGOAGXMBR-UHFFFAOYSA-N

物化性质

• 熔点：
  244-246 °C
• 沸点：
  368.2±15.0 °C(Predicted)
• 密度：
  1.366±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  68
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  quinolin-2-ylurea 生成 N,N'-bis-(2-quinolyl)urea
  参考文献：
  名称：

  Pajak, Janina; Lipczynska-Kochany, Ewa; Eckstein, Zygmunt, Polish Journal of Chemistry, 1982, vol. 56, # 3, p. 593 - 599

  摘要：

  DOI：
• 作为产物：
  描述：

  2-氯喹啉 在 2-二叔丁基膦-2′,4′,6′-三异丙基-3,6-二甲氧基-1,1′-联苯 、 palladium diacetate 、 caesium carbonate 、 三氟乙酸 作用下， 以 四氢呋喃 、 水 为溶剂， 反应 22.0h， 生成 quinolin-2-ylurea
  参考文献：
  名称：

  Synthesis of Unsymmetrical Diarylureas via Pd-Catalyzed C–N Cross-Coupling Reactions

  摘要：

  A facile synthesis of unsymmetrical N,N'-diarylureas is described. The utilization of the Pd-catalyzed arylation of ureas enables the synthesis of an array of diarylureas in good to excellent yields from benzylurea via a one-pot arylation-deprotection protocol, followed by a second arylation.

  DOI：

  10.1021/ol201210t

文献信息

• [EN] NOVEL PIPERIDINE DERIVATIVES<br/>[FR] DERIVES DE PIPERIDINE
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2004099180A1

  公开（公告）日：2004-11-18

  The invention relates to novel piperidine derivatives and related compounds of General Formula I and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as neurohormonal antagonists, in particular their use as urotensin II antagonists.

  该发明涉及新型哌啶衍生物和一般式I相关化合物，以及它们作为药物组合物制备中的活性成分的用途。该发明还涉及相关方面，包括制备这些化合物的过程、含有其中一种或多种化合物的药物组合物，特别是它们作为神经激素拮抗剂的用途，特别是它们作为尿苷Ⅱ拮抗剂的用途。
• [EN] PIPERAZINE-ALKYL-UREIDO DERIVATIVES<br/>[FR] DERIVES DE PIPERAZINE-ALKYLE-UREIDO
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2004099179A1

  公开（公告）日：2004-11-18

  The invention relates to novel piperazine derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as neurohormonal antagonists. (I)

  该发明涉及新型哌嗪衍生物和相关化合物，以及它们作为制备药物组成的活性成分的用途。该发明还涉及相关方面，包括制备这些化合物的过程、含有其中一种或多种化合物的药物组成，尤其是它们作为神经荷尔蒙拮抗剂的用途。
• [EN] PYRIDINE DERIVATIVES AND USE THEREOF AS UROTENSIN II ANTAGONISTS<br/>[FR] DERIVES DE PYRIDINE ET LEUR UTILISATION COMME ANTAGONISTES DE L'UROTENSINE II
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2005030209A1

  公开（公告）日：2005-04-07

  The invention relates to novel pyridine derivatives of formula 1 and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and their use as neurohormonal antagonists, especially as urotensin II inhibitors.

  该发明涉及公式1的新型吡啶衍生物和相关化合物，以及它们作为药物组成物中的活性成分的用途。该发明还涉及相关方面，包括制备这些化合物的过程、含有这些化合物中的一个或多个的药物组成物，以及它们作为神经荷尔蒙拮抗剂的用途，特别是作为尿泉素II抑制剂。
• Compounds, compositions and methods for modulating beta-amyloid production
  申请人：Active Pass Pharmaceuticals, Inc.

  公开号：US20030191144A1

  公开（公告）日：2003-10-09

  Methods and compositions useful in the treatment of amyloidosis and conditions and diseases associated therewith, such as Alzheimer's disease, are provided. The methods involve administering to a subject in need thereof a pharmaceutical composition including one or more agents that modulate PPAR&agr; and/or PPAR&dgr; activity, resulting in an inhibition of &bgr;-amyloid production and/or release from cells of the subject, particularly brain cells.

  提供了在治疗淀粉样变性及相关疾病和病况（如阿尔茨海默病）中有用的方法和组合物。这些方法涉及向需要治疗的对象施用包括一个或多个调节PPAR&agr;和/或PPAR&dgr;活性的药物组合物，导致抑制β-淀粉样蛋白从对象的细胞（尤其是脑细胞）中的产生和/或释放。
• [EN] 4-(PIPERIDYL- AND PYRROLIDYL-ALKYL-UREIDO) -QUINOLINES AS UROTENSIN II RECEPTOR ANTAGONISTS<br/>[FR] NOUVEAUX DERIVES DE QUINOLEINES
  申请人：ACTELION PHARMACEUTICALS LTD

  公开号：WO2003048154A1

  公开（公告）日：2003-06-12

  The invention relates to novel 1-pyridin-4-yl urea derivatives and related compounds and their use as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the compounds, pharmaceutical compositions containing one or more of those compounds and especially their use as neurohormonal antagonists.

  本发明涉及新型的1-吡啶-4-基脲衍生物及相关化合物，以及它们作为制备药物组合物的活性成分的用途。本发明还涉及相关方面，包括制备这些化合物的过程，含有这些化合物中的一个或多个的药物组合物，特别是它们作为神经荷尔蒙拮抗剂的用途。